Research

Scientists at the German Cancer Research Center (DKFZ), together with doctors from the Urological Clinic of the Mannheim University Hospital, have developed and successfully tested a chatbot based on artificial intelligence. “UroBot” was able to answer questions from the urology specialist examination with a high degree of accuracy, surpassing both other language models and the […]

iQMedix aims to improve the lives of cancer patients by providing personalized treatments based on molecular analysis. Using liquid biopsies to determine gene expression profiles from circulating tumor cells, iQMedix enables doctors to tailor therapies to each patient’s unique cancer. Their approach offers precise insights to determine effective treatments. Their vision is to make cancer […]

!LEVA specializes in guiding pharmaceutical companies through the complexities of development, from company foundation to early clinical studies. Over the past 25 years, the !LEVA management team has co-founded and successfully managed nearly a dozen companies, mainly in the pharmaceutical sector, while supporting numerous biotech companies in corporate and product development. !LEVA Sciences was founded […]

OLS – OMNI Life Science accelerates cell research with smart, reliable, and user-friendly technologies for life sciences and biotechnology. Their products are used in public, private, pharmaceutical, and biotech labs. The portfolio includes instruments, media, reagents, consumables, and services for Cell Counting, Culture, Imaging, Flow Cytometry, and Analysis. OLS supports researchers throughout the entire process, […]

Daiichi Sankyo’s European roots date back to the 1980s with branches in Düsseldorf. In 1990, Sankyo acquired Luitpold-Werke, a German pharmaceutical company, expanding operations to Pfaffenhofen, Germany, and Altkirch, France. In 2006, Daiichi and Sankyo merged, with European headquarters in Munich. Now present in 13 countries, Daiichi Sankyo employs over 2,000 people, making it one […]

SPT Labtech transforms the way scientists work by pioneering automation in liquid handling, sample preparation, and management for over 25 years. Their solutions streamline lab tasks, reduce human error, and ensure precise, consistent results. Using positive displacement technology, they enable ultra-low volume accuracy, saving reagents and samples. Their automated systems simplify sample storage and organization, […]

YUMAB GmbH (“YUMAB”), a leading antibody discovery CRO headquartered in Braunschweig, Germany, and MOLCURE Inc. (“MOLCURE”), an AI-driven drug discovery company based in Kawasaki, Japan, announced their on-going collaboration now includes advancing the application of zero-shot AI technology for antibody discovery. The collaboration brings together complementary expertise and technologies. MOLCURE has a decade of experience […]

Bacteria that are sensitive to drugs can become resilient when part of communities, with the help of cross-protection strategies Summary Many human medications can directly inhibit the growth and alter the function of the bacteria that constitute our gut microbiome. EMBL Heidelberg researchers have now discovered that this effect is reduced when bacteria form communities. […]

Heidelberg researchers identify biological mechanism that protects against, but can also trigger, errors in the genome Certain developmental signals shape not only the human embryo but also play a significant role in maintaining our genetic blueprints. They prevent alterations in the genome, known as mosaicism. An international research team led by scientists of the Centre […]